Search Results
Slidesets
State-of-the-art treatment of Hepatitis B | Cihan Yurdaydin, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Health Equity and Access to Medical Countermeasures
Presented at:
Lessons Learned from the Pandemic 2023: Redesigning Clinical Care, Research, and Public Health
Slidesets
Obstacles to use dose optimization in an [...] - Rene Bruno, PhD
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Dose Individualization Potential for Checkpoint Inhibitors - Stijn Koolen, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Relapse or reinfection of hepatitis C after direct acting antiviral treatment: unravelled by phylogenetic analysis. Results from the Spanish GEHEP-004 cohort - L. Cuypers
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Acute HCV and Reinfection | Loreta Kondili
Presented at:
European Meeting on HIV & Hepatitis 2024
Slidesets
Clinical Case from the Region: Three Times “Loss of Consciousness” in an HIV Patient -- Hongxin Zhao
Presented at:
Chinese HIV Clinical Forum Educational Series 2021
Slidesets
How to combine new treatments? Scientific approach | Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2016
Slidesets
Clinical Case Presentations – How to manage drug - drug interactions - the practice - Anna Maria Geretti, MD, PhD, FRCPath
Presented at:
European HIV Clinical Forum 2016
Slidesets
Skills improvement Session 2: Analyzing clinical datasets: Challenges and pitfalls - Amanda Mocroft, MD, PhD
Presented at:
HIV Clinical Forum 2015